Skip to main content
. 2017 Jul 19;11:1243–1252. doi: 10.2147/PPA.S137052

Table 1.

Perceived impact of the rheumatic disease on daily life domains and associated variables

(A) Percentage of patients responding to “how much do you consider your rheumatic disease impacts your…?”
None Mild Moderate Severe
Quality of life (n=569) (%) 15.6 32.5 32.2 19.7
Emotional well-being (n=571) (%) 19.3 39.8 26.6 14.4
Daily work or activities (n=565) (%) 16.3 34.5 28.0 21.2
Personal relationships (n=570) (%) 41.8 32.3 17.2 8.8
Family (close relatives) life (n=570) (%) 27.2 40.5 20.2 12.1
(B) Multivariable analysis of factors associated to perceived impact (“moderate/severe” versus “none/mild”) on different aspects of daily life
OR (95% CI) P-value
Quality of life
 Age (per quartile increase) 1.30 (1.08–1.58) 0.006
 Female gender (versus male) 1.62 (1.07–2.47) 0.024
 PsA (versus RA) 1.76 (1.04–2.97) 0.034
 Disease duration ≥10 years (versus <10 years) 1.72 (1.14–2.59) 0.009
Emotional well-being
 Female gender (versus male) 1.74 (1.14–2.67) 0.024
 PsA (versus RA) 1.66 (0.99–2.77) 0.055
 Disease duration ≥10 years (versus <10 years) 1.87 (1.24–2.87) 0.003
Daily work or activities
 Age (per quartile increase) 1.29 (1.07–1.56) 0.009
 Female gender (versus male) 1.91 (1.25–2.90) 0.003
 Axial SpA (versus RA) 1.61 (0.97–2.66) 0.066
 Disease duration ≥10 years (versus <10 years) 1.53 (1.02–2.31) 0.041
Personal relationships
 Female gender (versus male) 1.90 (1.61–3.11) 0.003
 Axial SpA (versus RA) 1.74 (0.98–3.09) 0.060
 PsA (versus RA) 1.73 (0.97–3.10) 0.065
 Disease duration ≥10 years (versus <10 years) 1.93 (1.19–3.12) 0.008
 Care from others (versus only self-care) 1.37 (1.08–1.74) 0.010
Family (close relatives) life
 Age (per quartile increase) 1.20 (0.97–1.47) 0.092
 Female gender (versus male) 2.01 (1.28–3.29) 0.003
 Disease duration ≥10 years (versus <10 years) 2.01 (1.27–3.12) 0.003
 Care from others (versus only self-care) 1.57 (1.25–1.98) <0.001

Abbreviations: CI, confidence interval; OR, odds ratio; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis.